David Anderson

692 total citations
14 papers, 534 citations indexed

About

David Anderson is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, David Anderson has authored 14 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 5 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in David Anderson's work include Liver Disease and Transplantation (4 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). David Anderson is often cited by papers focused on Liver Disease and Transplantation (4 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). David Anderson collaborates with scholars based in United Kingdom, Australia and Cuba. David Anderson's co-authors include Leonard W. Seymour, J Doran, Rachel Kerr, S S Burtles, David Ferry, Annie Young, P. J. Julyan, D. Ferry, David J. Kerr and Alice M. Young and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical Journal and Journal of Hepatology.

In The Last Decade

David Anderson

14 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Anderson United Kingdom 9 209 155 105 89 80 14 534
Priyanka Arora United States 8 119 0.6× 52 0.3× 39 0.4× 20 0.2× 29 0.4× 15 696
Nan Su China 12 210 1.0× 21 0.1× 76 0.7× 22 0.2× 47 0.6× 21 504
Yuji Komizu Japan 11 208 1.0× 94 0.6× 17 0.2× 46 0.5× 24 0.3× 38 378
Bowen Jiang China 13 223 1.1× 92 0.6× 5 0.0× 179 2.0× 38 0.5× 42 597
Weiguo Shi China 13 198 0.9× 32 0.2× 19 0.2× 22 0.2× 101 1.3× 50 483
Ivan S. Coulter Ireland 13 249 1.2× 44 0.3× 8 0.1× 12 0.1× 48 0.6× 22 632
Yonghua Liu China 15 190 0.9× 91 0.6× 7 0.1× 75 0.8× 62 0.8× 60 600
Yukari Nakagawa Japan 11 113 0.5× 23 0.1× 20 0.2× 30 0.3× 65 0.8× 19 381
Ankur Sharma India 15 231 1.1× 56 0.4× 9 0.1× 46 0.5× 35 0.4× 52 678

Countries citing papers authored by David Anderson

Since Specialization
Citations

This map shows the geographic impact of David Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Anderson more than expected).

Fields of papers citing papers by David Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Anderson. The network helps show where David Anderson may publish in the future.

Co-authorship network of co-authors of David Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of David Anderson. A scholar is included among the top collaborators of David Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Anderson. David Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Thakkar, Nilay, Rulan Griesel, Amy Pierce, et al.. (2025). Clinical Pharmacokinetics and Safety of a New HIV-1 Capsid Inhibitor, VH4004280, After Oral Administration in Adults Without HIV. Infectious Diseases and Therapy. 14(6). 1313–1326. 2 indexed citations
2.
Thakkar, Nilay, Rulan Griesel, Amy Pierce, et al.. (2025). Clinical Pharmacokinetics and Safety of Orally Administered VH4011499, a New HIV-1 Capsid Inhibitor, in Adults Without HIV. Infectious Diseases and Therapy. 14(5). 1011–1025. 2 indexed citations
3.
Howell, Jessica, Rohit Sawhney, Joseph Doyle, et al.. (2020). Validation of a novel rapid point-of-care ALT test in patients with viral hepatitis. Journal of Hepatology. 73. S812–S812. 3 indexed citations
4.
Guan, Ming, et al.. (2010). Seroprevalence of antibodies to hepatitis E virus in two large communities in Havana, Cuba. Transactions of the Royal Society of Tropical Medicine and Hygiene. 104(12). 772–776. 17 indexed citations
5.
Quintana, Ariel, et al.. (2008). Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998–2003. Journal of Medical Virology. 80(5). 798–802. 32 indexed citations
6.
Quintana, Ariel, et al.. (2005). Prevalence of antibodies to hepatitis E virus in residents of a district in Havana, Cuba. Journal of Medical Virology. 76(1). 69–70. 15 indexed citations
7.
Gazina, Elena V., et al.. (2005). Ion transport blockers inhibit human rhinovirus 2 release. Antiviral Research. 67(2). 98–106. 17 indexed citations
8.
Myint, Khin Saw Aye, Ming Guan, Lu Yang, et al.. (2005). EVALUATION OF A NEW RAPID IMMUNOCHROMATOGRAPHIC ASSAY FOR SERODIAGNOSIS OF ACUTE HEPATITIS E INFECTION. American Journal of Tropical Medicine and Hygiene. 73(5). 942–946. 28 indexed citations
9.
Morgan, Chris, et al.. (2004). Alarming Levels of Hepatitis B Virus Detected among Rural Tibetans. Tropical Doctor. 34(3). 156–156. 2 indexed citations
10.
Seymour, Leonard W., David Ferry, David Anderson, et al.. (2002). Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin. Journal of Clinical Oncology. 20(6). 1668–1676. 214 indexed citations
11.
Mulholland, Paul, D. Ferry, David Anderson, et al.. (2001). Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Annals of Oncology. 12(2). 245–248. 126 indexed citations
12.
Ferry, D., Mark Deakin, Simon R. Bramhall, et al.. (2000). A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints. Annals of Oncology. 11(9). 1165–1170. 15 indexed citations
13.
14.
Strain, Alastair J. & David Anderson. (1990). Lithium potentiates vasopressin-, angiotensin II-and noradrenaline-induced DNA synthesis in rat hepatocytes. Biochemical Society Transactions. 18(3). 455–455. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priyanka Arora Breakdown of academic impact, for papers by Nan Su Breakdown of academic impact, for papers by Yuji Komizu Breakdown of academic impact, for papers by Bowen Jiang Breakdown of academic impact, for papers by Weiguo Shi Breakdown of academic impact, for papers by Ivan S. Coulter Breakdown of academic impact, for papers by Yonghua Liu Breakdown of academic impact, for papers by Yukari Nakagawa Breakdown of academic impact, for papers by Ankur Sharma
Rankless by CCL
2026